• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

ESMO: Pfizer sees weight gain in cancer patients, aims to enter phase 3 in 2025

cafead

Administrator
Staff member
  • cafead   Sep 17, 2024 at 10:12: AM
via Cancer patients with wasting syndrome have gained weight after taking Pfizer’s anti-GDF-15 antibody in a midphase study, emboldening the Big Pharma to target a 2025 start date for its pivotal trial program.

article source
 

<